Issues related to pharmacy benefit management reforms.
2026 · 1st Quarter (Jan 1 - Mar 31)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THE NICKLES GROUP, LLC
- Filing UUID
- fbb6d78f-05de-4507-b5ef-0eb7007a3ed3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Most Favored Nation drug pricing.
Issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.